Chelator-functionalized glycosaminoglycans
US11479617B2 · kind B2 · utility
0Cited by
6References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2019 |
| Grant date | Oct 25, 2022 |
| Priority date | — |
| Expiry date | Aug 27, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08K2003/0862
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound includes a polysaccharide moiety and one or more chelating agents. The one or more chelating agents are covalently bonded to the polysaccharide moiety. The polysaccharide moiety can include a glycosaminoglycan moiety, such as a hyaluronic acid polymer or a sulfated glycosaminoglycan moiety. The compound can be used to treat or prevent a disease or disorder in a patient with a metal implant. The compound reduces a concentration of metal particulates or metal ions in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.